Guided Inhalation Manoeuvre During Nebulisation – Tracking and Analysing Users’ Breathing Technique
Authors: Carolina Dantas (Medical & Scientific Affairs), Pascal Förner (Research & Development) and Ulf Krüger (CEO)
27. January 2026
Effective aerosol delivery depends not only on the performance of the device, but also on how patients inhale. Variability in breathing manoeuvre remains one of the key factors influencing lung deposition, dosing consistency, and the reproducibility of nebulized therapies.
At the European Respiratory Society (ERS) Congress 2024 in Vienna, PULMOTREE presented the poster “Guided inhalation manoeuvre during nebulisation – tracking and analysing users’ breathing technique”, exploring how real-time feedback can support users in achieving a more controlled and consistent inhalation pattern during nebulization.
Using the Kolibri™ Mesh Nebulizer Platform with integrated feedback technology, the study analysed inhalation flow rate, inhalation duration, and user variability in first-time, untrained users. The findings show that guided inhalation can effectively reduce variability, helping users maintain targeted breathing patterns and improving overall reproducibility of aerosol delivery.
By combining precise aerosol generation with breathing guidance technology, the Kolibri™ Mesh Nebulizer Platform supports a more patient-centric approach to inhaled therapies and addresses one of the often-overlooked contributors to treatment variability: how patients actually breathe during inhaled therapies.
